These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2834022)

  • 1. Effect of alpha 1-adrenoceptors blockade with prazosin in canine narcolepsy.
    Mignot E; Guilleminault C; Bowersox S; Rappaport A; Dement WC
    Brain Res; 1988 Mar; 444(1):184-8. PubMed ID: 2834022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of central alpha-1 adrenoceptors in canine narcolepsy.
    Mignot E; Guilleminault C; Bowersox S; Rappaport A; Dement WC
    J Clin Invest; 1988 Sep; 82(3):885-94. PubMed ID: 2843574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep.
    Mignot E; Guilleminault C; Bowersox S; Frusthofer B; Nishino S; Maddaluno J; Ciaranello R; Dement WC
    Brain Res; 1989 Jun; 490(1):186-91. PubMed ID: 2569353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.
    Mignot E; Nishino S; Sharp LH; Arrigoni J; Siegel JM; Reid MS; Edgar DM; Ciaranello RD; Dement WC
    J Neurosci; 1993 Mar; 13(3):1057-64. PubMed ID: 8095066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 levels in cerebrospinal fluid of normal and narcoleptic dogs.
    Nishino S; Mignot E; Kilduff TS; Sakai T; Hayaishi O; Dement WC
    Biol Psychiatry; 1990 Nov; 28(10):904-10. PubMed ID: 2268692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsy.
    Nishino S; Mignot E; Fruhstorfer B; Dement WC; Hayaishi O
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2483-7. PubMed ID: 2928344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep.
    Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs.
    Wagner JL; Storb R; Storer B; Mignot E
    Tissue Antigens; 2000 Sep; 56(3):223-31. PubMed ID: 11034558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.
    Reid MS; Tafti M; Geary JN; Nishino S; Siegel JM; Dement WC; Mignot E
    Neuroscience; 1994 Apr; 59(3):511-22. PubMed ID: 8008205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of cataplexy in genetically narcoleptic Dobermans.
    Riehl J; Nishino S; Cederberg R; Dement WC; Mignot E
    Exp Neurol; 1998 Aug; 152(2):292-302. PubMed ID: 9710528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.
    Lin L; Faraco J; Li R; Kadotani H; Rogers W; Lin X; Qiu X; de Jong PJ; Nishino S; Mignot E
    Cell; 1999 Aug; 98(3):365-76. PubMed ID: 10458611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs.
    Mitler MM; Dement WC
    Electroencephalogr Clin Neurophysiol; 1977 Nov; 43(5):691-9. PubMed ID: 72649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic mechanisms in canine narcolepsy--II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy.
    Reid MS; Siegel JM; Dement WC; Mignot E
    Neuroscience; 1994 Apr; 59(3):523-30. PubMed ID: 8008206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep fragmentation in canine narcolepsy.
    Kaitin KI; Kilduff TS; Dement WC
    Sleep; 1986; 9(1 Pt 2):116-9. PubMed ID: 3704433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cataplexy-related neurons in the amygdala of the narcoleptic dog.
    Gulyani S; Wu MF; Nienhuis R; John J; Siegel JM
    Neuroscience; 2002; 112(2):355-65. PubMed ID: 12044453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy.
    Nishino S; Fruhstorfer B; Arrigoni J; Guilleminault C; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1079-84. PubMed ID: 8095546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical studies of human narcolepsy: alpha-adrenergic receptor autoradiography of human narcoleptic brain and brainstem.
    Aldrich MS; Prokopowicz G; Ockert K; Hollingsworth Z; Penney JB; Albin RL
    Sleep; 1994 Oct; 17(7):598-608. PubMed ID: 7846457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine narcolepsy is associated with an elevated number of alpha 2-receptors in the locus coeruleus.
    Fruhstorfer B; Mignot E; Bowersox S; Nishino S; Dement WC; Guilleminault C
    Brain Res; 1989 Oct; 500(1-2):209-14. PubMed ID: 2557958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic studies in narcolepsy, a disorder affecting REM sleep.
    Faraco J; Lin X; Li R; Hinton L; Lin L; Mignot E
    J Hered; 1999; 90(1):129-32. PubMed ID: 9987919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet alpha 2 adrenoceptors in human and canine narcolepsy.
    Valtier D; Nishino S; Guilleminault C; Dement WC; Mignot E
    Biol Psychiatry; 1991 Feb; 29(4):376-82. PubMed ID: 1645207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.